204 related articles for article (PubMed ID: 20620434)
1. Overview of platelet transfusion.
McCullough J
Semin Hematol; 2010 Jul; 47(3):235-42. PubMed ID: 20620434
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura.
Duffy SM; Coyle TE
J Clin Apher; 2013 Oct; 28(5):356-8. PubMed ID: 23720092
[TBL] [Abstract][Full Text] [Related]
3. Platelet transfusion. Current techniques, remaining problems, and future prospects.
Herman JH; Kamel HT
Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
[TBL] [Abstract][Full Text] [Related]
4. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
[TBL] [Abstract][Full Text] [Related]
5. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
[TBL] [Abstract][Full Text] [Related]
6. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding.
Slichter SJ
Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073
[TBL] [Abstract][Full Text] [Related]
7. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
9. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats.
Abrams-Ogg AC
Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205
[TBL] [Abstract][Full Text] [Related]
10. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
11. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
[TBL] [Abstract][Full Text] [Related]
12. Is platelet transfusion necessary prior to a central venous catheter placement in thrombotic thrombocytopenic purpura patients?
Ong M; Veillon D; Cotelingam J
J La State Med Soc; 2012; 164(5):283-4. PubMed ID: 23362594
[TBL] [Abstract][Full Text] [Related]
13. Determination of bleeding risk in thrombocytopenic patients with platelet transfusion therapy.
Kretschmer V; Huss B; Weber S; Bewarder S; Schulzki T; Köppler H; Heimanns J
Beitr Infusionsther Transfusionsmed; 1994; 32():434-6. PubMed ID: 9422122
[TBL] [Abstract][Full Text] [Related]
14. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
[TBL] [Abstract][Full Text] [Related]
15. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
16. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
17. Platelet transfusion therapy.
Slichter SJ
Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
[TBL] [Abstract][Full Text] [Related]
18. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
19. Optimizing platelet transfusion therapy.
Heal JM; Blumberg N
Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
[TBL] [Abstract][Full Text] [Related]
20. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection.
Lye DC; Lee VJ; Sun Y; Leo YS
Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]